Company news
Medical Marijuana, Inc. (OTC:MJNA) news
Medical Marijuana, Inc. news releases on 6ix. Latest, Feb 6, 2020: Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert…
Press releases — page 4
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson
February 6, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces New Chief Medical Officer
February 4, 2020
Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan
January 28, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Issues Update on Intellectual Property and Newly Acquired Patents
January 23, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Flagship Product Real Scientific Hemp Oil™ Featured in Us Weekly
January 21, 2020
Medical Marijuana, Inc. Subsidiary Kannaway Named Most Popular CBD MLM in 2020
January 16, 2020
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Opens Mexico City Office
January 14, 2020
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.
January 9, 2020
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™
January 8, 2020
HempMeds®, Subsidiary of Medical Marijuana, Inc., Becomes One of the First Companies to Join Recently Launched Leafly Market
December 19, 2019
Medical Marijuana, Inc. Appoints New Chief Financial Officer
December 17, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Showcases International Industry Leadership at European Parliament
December 11, 2019
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Commences Trading on OTCQB Under Ticker Symbol "KLFE"
December 10, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds ANVISA's New Regulations of Medical Cannabis Products in Brazil
December 5, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 Best in Biz Awards
December 3, 2019
HempMeds®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Sezzle to Offer New Stress-Free Payment Solution
November 26, 2019
Medical Marijuana, Inc. Reports $17.7 Million in Revenue in Q3 2019 Financial Results
November 22, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Invited to Speak on Key Panel at 2019 Marijuana Business Conference
November 19, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Alex Grapov to Chief Sales Officer
November 12, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Receives Two 2019 BIG Awards for Business
November 6, 2019
Medical Marijuana, Inc. and Subsidiaries' 2019 Sales Bookings Surpass Total 2018 Sales Bookings
November 5, 2019
Medical Marijuana, Inc. Hires Tyler Whatcott as Chief Technology Officer
October 31, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Speaks at HempToday™'s Latin American and Caribbean Hemp Summit
October 29, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Joins U.S. Hemp Roundtable Board of Directors
October 22, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Hemp for Humanity Educational Event Tour Throughout Japan
October 17, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Hosts Panel at Lide Futuro Debate in São Paulo
October 15, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division
October 10, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® and Company CEO Honored in 11th Annual Golden Bridge Awards
October 8, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Road to Area Tour
October 3, 2019
Medical Marijuana, Inc. CEO to Speak at Hemp for the Future Event in Reykjavík, Iceland
October 1, 2019
Medical Marijuana, Inc. Reaches One-Year Milestone in High-Level CBD Hemp Oil Stability Study
September 26, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Vice President Presents at MJBizDaily Latin American Cannabis Symposium
September 24, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Super Academy Event and Product Launch in Amsterdam
September 19, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Signs Agreement with Online Marketplace Dr. Cannabis
September 17, 2019
Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies
September 12, 2019
HempMeds®, Subsidiary of Medical Marijuana, Inc., Announces Presence at Natural Products Expo East
September 10, 2019
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hires Gabriel Barbosa as Scientific Projects and Regulatory Developing Analyst
September 5, 2019
Medical Marijuana, Inc. and Subsidiary Dixie Botanicals® Secure National News Coverage in Leading Financial Publication Benzinga
September 3, 2019
HempMeds®, Subsidiary of Medical Marijuana, Inc., Releases Hemp for Pets Product Line in Celebration on National Dog Day
August 26, 2019
Medical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics
August 22, 2019
Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie® Award Winners in 2019 International Business Awards®
August 20, 2019
Medical Marijuana, Inc. Reports $20.7 Million in Revenue in Q2 2019, Up 30% Year-Over-Year in Financial Results
August 15, 2019
HempMeds®, Subsidiary of Medical Marijuana, Inc., Announces Launch of New CBD Pet Product Line at SuperZoo 2019
August 14, 2019
Medical Marijuana, Inc. Announces Second Quarter Filing Date and Schedules Investor Conference Call for August 15, 2019
August 12, 2019
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch of Watermelon-Flavored CBD Gummies
August 7, 2019
Medical Marijuana, Inc. Subsidiaries HempMeds®, HempMeds® Mexico and HempMeds® Brasil Announce July 2019 as the Largest Sales Bookings Month in Company History
August 6, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products
August 1, 2019
Medical Marijuana, Inc. Begins Manufacturing Operations Under An Industrial Hemp Processor License
July 25, 2019
Medical Marijuana, Inc. Opens New Production & Warehousing Facility to Expedite International Expansion Efforts
July 23, 2019
Medical Marijuana, Inc. Subsidiary Kannaway® Grows International Leadership Team With Janne Heimonen as Managing Director of European Division
July 17, 2019